/BLFE

BLFE Stock - BioLife Sciences Inc.

Q: What is the analyst price target for BLFE?

Analyst price target information is not currently available for BLFE.

Q: What is BLFE's market cap?

Market capitalization information is not currently available for BLFE.

Healthcare|Medical - Instruments & Supplies|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for BLFE

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2016

FY2017

FY2018

FY2019

FY2020

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-2290.12

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	$411,695	N/A	N/A	N/A	N/A
Gross Profit	$-985,000	N/A	N/A	N/A	N/A
Gross Margin	-239.3%	N/A	N/A	N/A	N/A
Operating Income	$-1,244,000	N/A	$-42,280	$-329,000	$-12,500
Net Income	$-1,268,000	$-1,134	$-52,715	$-340,000	$-19,175
Net Margin	-308.0%	N/A	N/A	N/A	N/A
EPS	$-0.02	$-0.00	$-0.00	$-0.08	$-0.05

Company Overview

Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature screening technology. It offers disinfecting wipes, UV sterilization technology, electrostatic disinfection services, anti-microbial textiles, and touchless vending/marketplaces products. Bio Life Sciences Corp. was incorporated in 2018 and is based in Mississauga, Canada.

Visit Website

Frequently Asked Questions about BLFE

What is BLFE's current stock price?

BioLife Sciences Inc. (BLFE) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for BLFE?

No analyst price targets are currently available for this stock.

What sector is BioLife Sciences Inc. in?

BioLife Sciences Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.

What is BLFE's market cap?

BioLife Sciences Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does BLFE pay dividends?

No, BioLife Sciences Inc. does not currently pay a dividend to shareholders.